Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Regulatory Toxicology, Third Edition -

Regulatory Toxicology, Third Edition

Shayne C. Gad (Herausgeber)

Buch | Hardcover
354 Seiten
2018 | 3rd edition
Crc Press Inc (Verlag)
978-1-4987-8082-7 (ISBN)
CHF 319,95 inkl. MwSt
  • Versand in 10-15 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken
With three new chapters on Safety Data Sheet Preparation, Regulatory Requirements for GMOs, and Regulatory Requirements for Tobacco and Marijuana, this practical book provides toxicologists essential information on the regulations that govern their jobs and products. Each chapter covers the historical events that led to the original legislation.
This practical book provides toxicologists with essential information on the regulations that govern their jobs and products. Regulatory Toxicology, Third Edition is an up-to-date guide to required safety assessment for the entire range of man-made marketed products. Individual chapters written by experts with extensive experience in the field address requirements not only for human pharmaceuticals and medical devices (for which there are available guidances), but for the full range of man-made products. New in this edition are three chapters addressing Safety Data Sheet Preparation, Regulatory Requirements for GMOs, and Regulatory Requirements for Tobacco and Marijuana. The major administrative divisions for regulatory agencies and their main responsibilities are also detailed, as are the basic filing documents the agencies require.

Coverage includes food additives, dietary supplements, cosmetics, over-the-counter drugs, personal care and consumer products, agriculture and GMO products, industrial chemicals, air and drinking water regulations and the special cases of California’s Proposition 65, requirements for safety data sheets, and oversight regulations. Both US and international requirements are clearly presented and referenced. In one volume, those who have regulatory responsibility in companies, lawyers, educators, and those selling these materials in the marketplace can learn about regulatory requirements and how to meet them.

Editor Shayne C. Gad, BS (Whittier College, Chemistry and Biology, 1971) and PhD in Pharmacology/ Toxicology (Texas, 1977), DABT, is the principal of Gad Consulting Services, a twenty-five-yearold consulting firm with nine employees and more than 500 clients (including 140 pharmaceutical companies in the US and 50 overseas). Prior to this, he served in director-level and above positions at Searle, Synergen, and Beckton Dickinson. He has published 50 books and more than 350 chapters, articles, and abstracts in the fields of toxicology, statistics, pharmacology, drug development, and safety assessment. He has more than 40 years of broad-based experience in toxicology, drug and device development, statistics, and risk assessment. He has specific expertise in neurotoxicology, in vitro methods, cardiovascular toxicology, inhalation toxicology, immunotoxicology, and genotoxicology. Past president of the American College of Toxicology, the Roundtable of Toxicology Consultants, and three of SOT’s (Society of Toxicology) specialty sections. He has direct involvement in the preparation of Investigational New Drug applications (INDs, 115 successfully to date), New Drug Application (NDA), Product License Application (PLA), Abbreviated New Drug Application (ANDA), 501(k), Investigational Device Exemption (IDE), Common Technical Document (CTD), clinical data bases for phase 1 and 2 studies, and Premarket Approval Applications (PMAs). He has consulted for the Food and Drug Administration (FDA), Environmental Protection Agency (EPA), and National Institutes of Health (NIH), has trained reviewers, and has been an expert witness for the FDA. He has also conducted the triennial toxicology salary survey as a service to the profession for the last 29 years. Dr. Gad is also a retired Navy officer with more than 26 years in service.

Introduction. Human Pharmaceutical Products. Animal Health Products. Regulatory Aspects and Strategy in Medical Device and Bio Materials Safety Evaluation. Food Additives and Nutrition Supplements. Regulations Affecting Cosmetic and Over-the-counter Drug Products. OTC Drugs and Nutraceuticals. Consumer Products: Non-personal Care Products. Agricultural Chemicals: Regulation, Risk Assessment, and Risk Management. Industrial Chemicals: International Regulation of New and Existing Chemicals (REACH, the New Toxic Substances Control Act and Similar Worldwide Chemical Control Laws). Industrial Chemicals: Hazard Communication, Exposure Limits, Labeling and Other Workplace and Transportation Requirements under OSHA, DOT, and Similar Authorities Around the World. Federal Air and Water Regulations: SDWA, CAA, HAPS and Ozone Regulation. Understanding the Safe Drinking Water and Toxic Enforcement Act of 1986 (California’s Proposition 65). Safety Data Sheets (SDSs). GMOs (Internationally). Tobacco and Marijuana. Oversight regulations.

Erscheinungsdatum
Zusatzinfo 97 Tables, black and white; 15 Illustrations, black and white
Verlagsort Bosa Roca
Sprache englisch
Maße 178 x 254 mm
Gewicht 918 g
Themenwelt Naturwissenschaften Biologie Biochemie
Technik
ISBN-10 1-4987-8082-2 / 1498780822
ISBN-13 978-1-4987-8082-7 / 9781498780827
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich

von Reinhard Matissek; Andreas Hahn

Buch | Hardcover (2024)
Springer Spektrum (Verlag)
CHF 109,95

von Birgit Piechulla; Hans Walter Heldt

Buch | Hardcover (2023)
Springer Spektrum (Verlag)
CHF 109,95